Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123


S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.

Virk-Baker MK, Barnes S, Krontiras H, Nagy TR.

Nutr Res. 2014 Feb;34(2):116-25. doi: 10.1016/j.nutres.2013.12.002. Epub 2013 Dec 18.


Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study.

Lee SA, Shu XO, Li H, Yang G, Cai H, Wen W, Ji BT, Gao J, Gao YT, Zheng W.

Am J Clin Nutr. 2009 Jun;89(6):1920-6. doi: 10.3945/ajcn.2008.27361. Epub 2009 Apr 29.


Perspectives on the soy-breast cancer relation.

Messina M, Wu AH.

Am J Clin Nutr. 2009 May;89(5):1673S-1679S. doi: 10.3945/ajcn.2009.26736V. Epub 2009 Apr 1.


Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.

Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ.

Breast Cancer Res Treat. 2009 Nov;118(2):395-405. doi: 10.1007/s10549-009-0321-5. Epub 2009 Feb 17.


Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies.

Chen M, Rao Y, Zheng Y, Wei S, Li Y, Guo T, Yin P.

PLoS One. 2014 Feb 20;9(2):e89288. doi: 10.1371/journal.pone.0089288. eCollection 2014.


Epidemiology of soy exposures and breast cancer risk.

Wu AH, Yu MC, Tseng CC, Pike MC.

Br J Cancer. 2008 Jan 15;98(1):9-14. doi: 10.1038/sj.bjc.6604145. Epub 2008 Jan 8. Review.


Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies.

Dong JY, Qin LQ.

Breast Cancer Res Treat. 2011 Jan;125(2):315-23. doi: 10.1007/s10549-010-1270-8. Epub 2010 Nov 27. Review.


Soy products in the management of breast cancer.

Magee PJ, Rowland I.

Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):586-91. doi: 10.1097/MCO.0b013e328359156f. Review.


Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County.

Wu AH, Yu MC, Tseng CC, Twaddle NC, Doerge DR.

Carcinogenesis. 2004 Jan;25(1):77-81. Epub 2003 Oct 10.


Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Messina MJ, Wood CE.

Nutr J. 2008 Jun 3;7:17. doi: 10.1186/1475-2891-7-17. Review.


Associations between soy, diet, reproductive factors, and mammographic density in Singapore Chinese women.

Ursin G, Sun CL, Koh WP, Khoo KS, Gao F, Wu AH, Yu MC.

Nutr Cancer. 2006;56(2):128-35.


Relationship between soy food intake and breast cancer in China.

Zhu YY, Zhou L, Jiao SC, Xu LZ.

Asian Pac J Cancer Prev. 2011;12(11):2837-40.


Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status.

Woo HD, Park KS, Ro J, Kim J.

Nutr Cancer. 2012;64(2):198-205. doi: 10.1080/01635581.2012.635261. Epub 2012 Jan 2.


Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.

van der Velpen V, Hollman PC, van Nielen M, Schouten EG, Mensink M, Van't Veer P, Geelen A.

Eur J Clin Nutr. 2014 Oct;68(10):1141-7. doi: 10.1038/ejcn.2014.108. Epub 2014 Jun 18.


Soy intake and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.

Nagata C, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, Wakai K, Inoue M, Tsugane S, Sasazuki S; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan.

Jpn J Clin Oncol. 2014 Mar;44(3):282-95. doi: 10.1093/jjco/hyt203. Epub 2014 Jan 22. Review.


Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Center-based prospective study.

Budhathoki S, Iwasaki M, Sawada N, Yamaji T, Shimazu T, Sasazuki S, Inoue M, Tsugane S; JPHC Study Group.

BJOG. 2015 Feb;122(3):304-11. doi: 10.1111/1471-0528.12853. Epub 2014 Jun 18.


Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status.

Zhang C, Ho SC, Lin F, Cheng S, Fu J, Chen Y.

Cancer Sci. 2010 Feb;101(2):501-7. doi: 10.1111/j.1349-7006.2009.01376.x. Epub 2009 Sep 29.


Epidemiologic studies of isoflavones & mammographic density.

Maskarinec G, Verheus M, Tice JA.

Nutrients. 2010 Jan;2(1):35-48. doi: 10.3390/nu2010035. Epub 2010 Jan 19. Review.


Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy.

Kang X, Zhang Q, Wang S, Huang X, Jin S.

CMAJ. 2010 Nov 23;182(17):1857-62. doi: 10.1503/cmaj.091298. Epub 2010 Oct 18.

Supplemental Content

Support Center